The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11032 results:
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
Georgianos, P. I., Sarafidis P. A., Sinha A. D., & Agarwal, iv R. (2015).  Adverse effects of conventional thrice-weekly hemodialysis: is it time to avoid 3-day interdialytic intervals?. Am J Nephrol. 41(4-5), 400-8.
Georgianos, P. I., Vaios V., Leontaridou E., Karayannopoulou G., Koletsa T., Sioulis A., et al. (2019).  Acute Interstitial Nephritis in a Patient with Non-Small Cell Lung Cancer under Immunotherapy with Nivolumab.. Case Rep Nephrol. 2019, 3614980.
Georgianos, P. I., Tziatzios G., Roumeliotis S., Vaios V., Sgouropoulou V., Tsalikakis D. G., et al. (2023).  Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on cardiovascular outcomes in dialysis patients: a systematic review and meta-analysis.. Nephrol Dial Transplant. 38(1), 203-211.
Georgianos, P. I., Vaios V., Eleftheriadis T., Papachristou E., & Liakopoulos V. (2023).  Therapeutic Advances in Diabetic Kidney Disease.. Int J Mol Sci. 24(3), 
Georgianos, P. I., Champidou E., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2018).  Home blood pressure-guided antihypertensive therapy in chronic kidney disease: more data are needed.. J Am Soc Hypertens. 12(4), 242-247.
Georgianos, P. I., & Sarafidis P. A. (2015).  Pro: Should we move to more frequent haemodialysis schedules?. Nephrol Dial Transplant. 30(1), 18-22.
Georgianos, P. I., Pikilidou M. I., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2018).  Arterial stiffness in end-stage renal disease-pathogenesis, clinical epidemiology, and therapeutic potentials.. Hypertens Res. 41(5), 309-319.
Georgianos, P. I., Sarafidis P. A., Haidich A-B., Karpetas A., Stamatiadis D., Nikolaidis P., et al. (2013).  Diverse effects of interdialytic intervals on central wave augmentation in haemodialysis patients.. Nephrol Dial Transplant. 28(8), 2160-9.
Georgianos, P. I., Mpoutsiouki F., Sabani E., Stamatiadis D. N., Liakopoulos V., Balaskas E. V., et al. (2016).  Hemodialysis patients with intradialytic rise in blood pressure display higher baseline aortic stiffness and negligible drop in augmentation index with dialysis.. Int Urol Nephrol. 48(4), 601-8.
Georgianos, P. I., Vaios V., Eleftheriadis T., Zebekakis P. E., & Liakopoulos V. (2020).  Pulse wave velocity assessment for cardiovascular risk prognostication in ESKD: weighing recent evidence.. Curr Vasc Pharmacol.
Georgianos, P. I., Vaios V., Divani M., & Liakopoulos V. (2023).  Should we discontinue RAS-inhibitor therapy in patients with advanced CKD?. Expert Opin Pharmacother.
Georgianos, P. I., Morfesis P., & Zebekakis P. E. (2017).  Exploring the association of arterial stiffness with estimated glomerular filtration rate: another chicken-egg paradigm?. J Hypertens. 35(3), 650-651.
Georgianos, P. I., Vaios V., Sgouropoulou V., & Liakopoulos V. (2022).  The interaction of estimated glomerular filtration rate with circadian blood pressure variation: do not forget the impact of albuminuria.. J Hypertens. 40(7), 1432-1433.
Georgianos, P. I., Sarafidis P. A., & Lasaridis A. N. (2013).  Arterial Stiffness: a Novel Cardiovascular Risk Factor in Kidney Disease Patients.. Curr Vasc Pharmacol.
Georgianos, P. I., Vaios V., Zebekakis P. E., & Liakopoulos V. (2020).  Blood pressure targets in patients with chronic kidney disease: A critical evaluation of clinical-trial evidence and guideline recommendations.. J Clin Hypertens (Greenwich). 22(5), 924-928.
Georgianos, P. I., Sarafidis P. A., Liakopoulos V., Balaskas E. V., & Zebekakis P. E. (2016).  Mineralocorticoid Receptor Antagonism for Cardiovascular Protection in End-Stage Renal Disease: New Data But the Controversy Continues.. J Clin Hypertens (Greenwich). 18(3), 197-9.
Georgianos, P. I., Sarafidis P. A., Karpetas A., Kosmidis D., Sioulis A., Liakopoulos V., et al. (2014).  Hemodiafiltration does not have additional benefits over hemodialysis on arterial stiffness, wave reflections and central aortic pressures.. Blood Purif. 37(1), 18-26.
Georgianos, P. I., Liampas I., Kyriakou A., Vaios V., Raptis V., Savvidis N., et al. (2017).  Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease.. Int Urol Nephrol. 49(12), 2217-2221.
Georgianos, P. I., Divani M., Eleftheriadis T., Mertens P. R., & Liakopoulos V. (2019).  SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?. Curr Med Chem. 26(29), 5564-5578.
Georgianos, P. I., Dounousi E., & Liakopoulos V. (2023).  Albuminuria and cardiorenal risk.. Curr Opin Cardiol.
Georgianos, P. I., Sarafidis P. A., & Liakopoulos V. (2015).  Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression?. Am J Hypertens. 28(8), 958-65.
Georgianos, P. I., Eleftheriadis T., & Liakopoulos V. (2023).  Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?. Eur J Clin Invest. 53(2), e13864.
Georgianos, P. I., Vaios V., Sgouropoulou V., Eleftheriadis T., Tsalikakis D. G., & Liakopoulos V. (2022).  Hypertension in Dialysis Patients: Diagnostic Approaches and Evaluation of Epidemiology.. Diagnostics (Basel). 12(12), 
Georgianos, P. I., Vaios V., Eleftheriadis T., Zebekakis P., & Liakopoulos V. (2017).  Mineralocorticoid Antagonists in ESRD: An Overview of Clinical Trial Evidence.. Curr Vasc Pharmacol. 15(6), 599-606.
Georgianos, P. I., & Sarafidis P. A. (2015).  Opponent's comment.. Nephrol Dial Transplant. 30(1), 27-8.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.